Kirkland Advises Curewell Capital on $535 Million Oversubscribed Inaugural Fund
Kirkland & Ellis advised Curewell Capital, a private equity firm focused on building industry-leading middle-market healthcare companies, on the formation and closing of Curewell Capital I, LP at its hard cap of $535 million. The inaugural fund was raised in a single closing and completed less than five months after launch. The fund builds on the team’s established strategy of acquiring leading U.S. healthcare businesses across healthcare services, pharmaceutical services, medical devices and healthcare technology.
The Kirkland team included investment funds lawyers Dave Stults, Yong-Nam Jun, Michael Shea, Matt Cohen and Myunghee Sim; and tax lawyer Michael Alcan.
